Company news
Personalis, Inc. news in 2023
Personalis, Inc.'s news releases, calls and decks from 2023, newest first.
Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives
December 3, 2023
Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing
November 27, 2023
Personalis Reports Third Quarter 2023 Financial Results
November 6, 2023
Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer
October 25, 2023
Personalis to Announce Third Quarter 2023 Financial Results
October 23, 2023
Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
October 20, 2023
Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
October 18, 2023
Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
October 17, 2023
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
August 28, 2023
Personalis Reports Second Quarter 2023 Financial Results
August 7, 2023
Personalis to Announce Second Quarter 2023 Financial Results
July 24, 2023
Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics
June 25, 2023
Dr. Kenneth J. Widder Joins Personalis Board of Directors
June 12, 2023
Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
May 29, 2023
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
May 15, 2023
Personalis Reports First Quarter 2023 Financial Results
May 2, 2023
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
May 1, 2023
Personalis to Announce First Quarter 2023 Financial Results
April 18, 2023
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
April 4, 2023
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
April 4, 2023
Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
March 21, 2023
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
March 6, 2023
Personalis Appoints Christopher Hall as Chief Executive Officer
March 1, 2023
Personalis Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results
February 8, 2023
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
February 2, 2023
Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
January 3, 2023
Calls in 2023
Decks in 2023
- ESMO Congress 2023
Conference · 15 slides · Oct 21, 2023